Skip to main content

Non-hodgkin lymphoma

Screening, diagnosis and staging

22-05-2017 | Lymphoma | Article

Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI

Kirchner J, Deuschl C, Schweiger B et al. Eur J Nucl Med Mol Imaging 2017; 44: 1742-1750. doi:10.1007/s00259-017-3726-0

14-10-2016 | Hematologic cancers | Article

T-cell lymphomas, a challenging disease: types, treatments, and future

Ma H & Abdul-Hay M. Int J Clin Oncol 2017; 22: 18–51. doi:10.1007/s10147-016-1045-2

28-09-2016 | Hematologic cancers | Book chapter | Article


In: Handbook of Lymphoma. Edited by Younes A. Springer International Publishing, 2016. doi:10.1007/978-3-319-08467-1_4

01-08-2016 | Lymphoma | Article

Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine

An expert summary of the diagnostic and prognostic value of biomarkers related to alterations in the most common types of lymphoma at the genetic, epigenetic, protein, and tumor microenvironment levels.

Mod Pathol 2016; 29: 1118–1142. doi:10.1038/modpathol.2016.92

05-07-2016 | Hematologic cancers | Book chapter | Article

PET/CT for HL staging

An illustrative overview of the importance of positron emission tomography and computed tomography for the prognostication and staging of Hodgkin lymphoma.

Hutchings M, Loft A, & El-Galaly TC. In: PET Scan in Hodgkin Lymphoma. Edited by Gallamini A. Springer International Publishing, 2016. doi:10.1007/978-3-319-31797-7_1

04-01-2016 | Pancreatic cancer | Article

Current update on primary pancreatic lymphoma

This article reviews the computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) CT findings of primary and secondary pancreatic lymphomas and discusses the role of endoscopic ultrasound-guided fine needle aspiration in diagnosis and management.

Anand D et al. Abdom Radiol 2016; 41: 347–355. doi:10.1007/s00261-015-0620-8

01-09-2015 | Hematologic cancers | Article

Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma

Howell et al determine that hematological malignancies have varying presentations by subtype but there is a worrying lack of public awareness of the differing clinical presentations, which is causing delayed diagnosis.

Br J Cancer 2015; 113: 1114–1120. doi:10.1038/bjc.2015.311

07-02-2015 | Hematologic cancers | Book chapter | Article

Imaging of non-hodgkin lymphomas: diagnosis and response-adapted strategies

This review evaluates the use of imaging in patients with non-Hodgkin lymphoma before, during, and after therapy with an insight into future developments in the field including new positron emission tomography tracers.

El-Galaly TC & Hutchings M. In: Non-Hodgkin Lymphoma. Edited by Evens AM & Blum KA. Springer International Publishing, 2015. doi:10.1007/978-3-319-13150-4_5

05-12-2014 | Hematologic cancers | Book chapter | Article

Functional imaging in hodgkin lymphoma

The authors review the functional imaging techniques used for staging and response assessment in Hodgkin lymphoma including the use of positron emission tomography and magnetic resonance imaging.

Gallamini A, Hutchings M, & Borra A. In: Hodgkin Lymphoma. Edited by Engert A & Younes A. Springer International Publishing, 2015. doi:10.1007/978-3-319-12505-3_7

Image Credits